{"id":23116,"date":"2016-07-13T08:42:29","date_gmt":"2016-07-13T07:42:29","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=23116"},"modified":"2016-07-13T08:42:29","modified_gmt":"2016-07-13T07:42:29","slug":"tractaments-de-tabaquisme-presentacio-de-lestudi-eagles","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","title":{"rendered":"Tratamientos de tabaquismo: presentaci\u00f3n del estudio EAGLES"},"content":{"rendered":"<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/estudi-eagles-portada.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignright  wp-image-23120\" alt=\"estudi-eagles-portada\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/estudi-eagles-portada.jpg\" width=\"272\" height=\"199\" \/><\/a>La<b>estudio EAGLES (Evaluating Adverse Events in en Global Smoking Cessation Study) <\/b>es uno <strong>trabajo sobre la seguridad y eficacia de los tratamientos farmacol\u00f3gicos del cese tab\u00e1quico en pacientes neuropsiqui\u00e1tricos<\/strong>. El 6 de julio se present\u00f3, por primera vez en el Estado, en la sede del COFB, en un acto organizado por la\u00a0<a href=\"http:\/\/www.academia.cat\/\" target=\"_blank\" rel=\"noopener\">Sociedad Catalana de Atenci\u00f3n y Tratamiento del Consumo del Tabaco (SCATT)<\/a> en colaboraci\u00f3n con el Consejo de Colegios Farmac\u00e9uticos de Catalu\u00f1a, el Colegio de Farmac\u00e9uticos de Barcelona y la Academia de Ciencias M\u00e9dicas de Catalu\u00f1a y de Baleares.<\/p>\n<figure id=\"attachment_23124\" aria-describedby=\"caption-attachment-23124\" style=\"width: 306px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/presentacio-estudi-EAGLES-tabaquisme-COFB-1.jpg\"><img decoding=\"async\" class=\"wp-image-23124\" alt=\"presentacio-estudi-EAGLES-tabaquisme-COFB (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/presentacio-estudi-EAGLES-tabaquisme-COFB-1.jpg\" width=\"306\" height=\"204\" \/><\/a><figcaption id=\"caption-attachment-23124\" class=\"wp-caption-text\">De izquierda a derecha: Eugeni Bruguera, Guillermo Bagaria, \u00c1ngela Mart\u00ednez y S\u00edlvia Mond\u00f3n<\/figcaption><\/figure>\n<p>El acto corri\u00f3 a cargo de<b>Eugeni Bruguera<\/b>, jefe de la Unidad de Conductas Adictivas y de la Unidad de Tabaquismo del Servicio de Psiquiatr\u00eda del Hospital Universitari Vall d&#039;Hebron de Barcelona, y\u00a0<b>Silvia Mond\u00f3n<\/b>, de la Unidad de Conductas Adictivas del Servicio de Psiquiatr\u00eda del Instituto de Neurociencias del Hospital Cl\u00ednic de Barcelona, dos de los tres investigadores principales, junto con <b>Cristina Pinet<\/b>. Presentaron <b>\u00c1ngela Mart\u00ednez<\/b>, presidenta del SCATT, y <b>Guillermo Bagaria<\/b>, vocal de la Junta de Gobierno del COFB.<\/p>\n<div class=\"box shadow\">En el estudio participaron 140 centros de 16 pa\u00edses con 8.144 fumadores categorizados en dos cohortes: 4.116 pacientes psiqui\u00e1tricos y 4028 no psiqui\u00e1tricos. <b>Concluye que tanto la vareniclina<\/b> (agonista nicot\u00ednico)<b> como el bupropi\u00f3n <\/b>(antidepresivo, deshabituador del tabaco)<b> no tienen efectos adversos neuropsiqui\u00e1tricos significativos respecto al placebo<\/b>. Todos los tratamientos analizados (vareniclina, bupropi\u00f3n y TSN) son m\u00e1s efectivos que el placebo.<\/p>\n<p>La prestigiosa revista <i>The Lancet<\/i> public\u00f3 en el mes de abril los datos del estudio EAGLES. Este ensayo es, hasta la fecha, el estudio cl\u00ednico m\u00e1s destacado que ha evaluado las opciones farmacol\u00f3gicas disponibles para dejar de fumar.<\/p>\n<p><a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(16)30272-0\/abstract\" target=\"_blank\" rel=\"noopener\">Ver publicaci\u00f3n en The Lancet<\/a><\/div>\n<p><b>Las conclusiones m\u00e1s relevantes son: <\/b><\/p>\n<ul>\n<li>La seguridad mostrada de todos los tratamientos.<\/li>\n<li>La seguridad demostrada tambi\u00e9n en pacientes con problemas psiqui\u00e1tricos controlados.<\/li>\n<li>El paciente psiqui\u00e1trico puede tratarse con cualquiera de los tres f\u00e1rmacos estudiados.<\/li>\n<li>Demostrada la eficacia de todos los tratamientos farmacol\u00f3gicos frente a placebo y por tanto su evidencia cient\u00edfica.<\/li>\n<li>Que en las dosis estudiadas y en monoterapia, el tratamiento con la vareniclina es el que proporciona un mayor porcentaje de cese, comparado con los dem\u00e1s.<\/li>\n<\/ul>\n<p>\u201cA partir de este estudio <b>se elimina la advertencia de riesgo asociado de la vareniclina y del bupropi\u00f3n de sus prospectos<\/b>. Otra consecuencia destacable es que <b>los pacientes fumadores con antecedentes psiqui\u00e1tricos estables podr\u00e1n utilizar cualquiera de los tres tratamientos para dejar de fumar sin temor a que su patolog\u00eda de base sea agravada<\/b>. Es conocido que el abandono del tabaco en enfermo mental favorece su situaci\u00f3n personal y mejora su estado en general. Por tanto, son los m\u00e1s beneficiados del resultado de este estudio\u201d explica <b>Montserrat Moral<\/b>, vicepresidenta del SCATT.<\/p>\n<p>\u201cAl finalizar la exposici\u00f3n hubo un interesante y espont\u00e1neo debate sobre las posibilidades que abre este estudio en el uso de las herramientas farmacol\u00f3gicas y la colaboraci\u00f3n entre los diferentes profesionales sanitarios que abordan el cese tab\u00e1quico y en el que el col colectivo farmac\u00e9utico tiene un importante papel a aportar\u201d concluye <strong>Guillermo Bagaria<\/strong>, vocal del COFB.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/presentacio-estudi-EAGLES-tabaquisme-COFB-4.jpg\"><img decoding=\"async\" class=\"wp-image-23126 aligncenter\" alt=\"presentacio-estudi-EAGLES-tabaquisme-COFB (4)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/presentacio-estudi-EAGLES-tabaquisme-COFB-4.jpg\" width=\"594\" height=\"343\" \/><\/a><\/p>\n<p><b>Quiz\u00e1s tambi\u00e9n te interesa:<\/b><\/p>\n<ul>\n<li><a href=\"http:\/\/blog.cofb.cat\/setmana-sense-fum-decideix-te-a-deixar-de-fumar-el-farmaceutic-et-pot-ajudar\/\">Semana sin humo: dec\u00eddete a dejar de fumar, el farmac\u00e9utico te puede ayudar<\/a> (Blog)<\/li>\n<li><a href=\"http:\/\/blog.cofb.cat\/la-farmacia-present-en-la-vi-jornada-de-la-societat-catalana-datencio-i-tractament-del-consum-de-tabac\/\">La farmacia, presente en la VI Jornada de la Sociedad Catalana de Atenci\u00f3n y Tratamiento del Consumo de Tabaco<\/a> (Blog)<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>El estudio EAGLES (Evaluating Adverse Events in Global Smoking Cessation Study) es un trabajo sobre la seguridad y eficacia de los tratamientos farmacol\u00f3gicos del cese tab\u00e1quico en pacientes neuropsiqui\u00e1tricos. El 6 de julio se present\u00f3, por primera vez en el Estado, en la sede del COFB, en un acto organizado [\u2026]<\/p>","protected":false},"author":1,"featured_media":23120,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[64,2441,2358,137,138],"class_list":["post-23116","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-farmaceutica","tag-estudi-eagles","tag-scatt","tag-tabac","tag-tabaquisme"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"L&#8217;estudi EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) \u00e9s un treball sobre la seguretat i efic\u00e0cia dels tractaments farmacol\u00f2gics de la cessaci\u00f3 tab\u00e0quica en pacients neuropsiqui\u00e0trics. El 6 de juliol es va presentar, per primer cop a l\u2019Estat, a la seu del COFB, en un acte organitzat [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-07-13T07:42:29+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES\",\"datePublished\":\"2016-07-13T07:42:29+00:00\",\"dateModified\":\"2016-07-13T07:42:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\"},\"wordCount\":632,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"estudi EAGLES\",\"SCATT\",\"tabac\",\"tabaquisme\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\",\"name\":\"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-07-13T07:42:29+00:00\",\"dateModified\":\"2016-07-13T07:42:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","og_locale":"es_ES","og_type":"article","og_title":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"L&#8217;estudi EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) \u00e9s un treball sobre la seguretat i efic\u00e0cia dels tractaments farmacol\u00f2gics de la cessaci\u00f3 tab\u00e0quica en pacients neuropsiqui\u00e0trics. El 6 de juliol es va presentar, per primer cop a l\u2019Estat, a la seu del COFB, en un acte organitzat [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-07-13T07:42:29+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES","datePublished":"2016-07-13T07:42:29+00:00","dateModified":"2016-07-13T07:42:29+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/"},"wordCount":632,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","estudi EAGLES","SCATT","tabac","tabaquisme"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","url":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","name":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-07-13T07:42:29+00:00","dateModified":"2016-07-13T07:42:29+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"L&#8217;estudi EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) \u00e9s un treball sobre la seguretat i efic\u00e0cia dels tractaments farmacol\u00f2gics de la cessaci\u00f3 tab\u00e0quica en pacients neuropsiqui\u00e0trics. El 6 de juliol es va presentar, per primer cop a l\u2019Estat, a la seu del COFB, en un acte organitzat [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/23116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=23116"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/23116\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=23116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=23116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=23116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}